212 related articles for article (PubMed ID: 21300446)
21. EMMPRIN expression as a prognostic factor in radiotherapy of cervical cancer.
Ju XZ; Yang JM; Zhou XY; Li ZT; Wu XH
Clin Cancer Res; 2008 Jan; 14(2):494-501. PubMed ID: 18223224
[TBL] [Abstract][Full Text] [Related]
22. Prognostic factors in neuroendocrine small cell cervical carcinoma: a multivariate analysis.
Chan JK; Loizzi V; Burger RA; Rutgers J; Monk BJ
Cancer; 2003 Feb; 97(3):568-74. PubMed ID: 12548598
[TBL] [Abstract][Full Text] [Related]
23. The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy.
Tsai CS; Lai CH; Wang CC; Chang JT; Chang TC; Tseng CJ; Hong JH
Gynecol Oncol; 1999 Dec; 75(3):328-33. PubMed ID: 10600284
[TBL] [Abstract][Full Text] [Related]
24. Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion.
Huguet F; Cojocariu OM; Levy P; Lefranc JP; Darai E; Jannet D; Ansquer Y; Lhuillier PE; Benifla JL; Seince N; Touboul E
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1508-15. PubMed ID: 18676093
[TBL] [Abstract][Full Text] [Related]
25. High dose-rate intracavitary brachytherapy for cervical carcinomas with lower vaginal infiltration.
Kazumoto T; Kato S; Tabushi K; Kutsutani-Nakamura Y; Mizuno H; Takahashi M; Shiromizu K; Saito Y
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1157-66. PubMed ID: 17459604
[TBL] [Abstract][Full Text] [Related]
26. Expressional STAT3/STAT5 Ratio is an Independent Prognostic Marker in Colon Carcinoma.
Klupp F; Diers J; Kahlert C; Neumann L; Halama N; Franz C; Schmidt T; Lasitschka F; Warth A; Weitz J; Koch M; Schneider M; Ulrich A
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1548-55. PubMed ID: 25773877
[TBL] [Abstract][Full Text] [Related]
27. Comparative study of LDR (Manchester system) and HDR image-guided conformal brachytherapy of cervical cancer: patterns of failure, late complications, and survival.
Narayan K; van Dyk S; Bernshaw D; Rajasooriyar C; Kondalsamy-Chennakesavan S
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1529-35. PubMed ID: 19473780
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of signal transducer and activator of transcription 1 activation in breast cancer.
Widschwendter A; Tonko-Geymayer S; Welte T; Daxenbichler G; Marth C; Doppler W
Clin Cancer Res; 2002 Oct; 8(10):3065-74. PubMed ID: 12374673
[TBL] [Abstract][Full Text] [Related]
29. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.
Eifel PJ; Winter K; Morris M; Levenback C; Grigsby PW; Cooper J; Rotman M; Gershenson D; Mutch DG
J Clin Oncol; 2004 Mar; 22(5):872-80. PubMed ID: 14990643
[TBL] [Abstract][Full Text] [Related]
30. Tumor heterogeneity of FIGO stage III carcinoma of the uterine cervix.
Kim YB; Lee IJ; Kim SY; Kim JW; Yoon HI; Kim SW; Kim S; Kim YT; Suh CO; Kim GE
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1323-8. PubMed ID: 19467800
[TBL] [Abstract][Full Text] [Related]
31. The significance of tumoral ERCC1 status in patients with locally advanced cervical cancer treated with chemoradiation therapy: a multicenter clinicopathologic analysis.
Doll CM; Aquino-Parsons C; Pintilie M; Klimowicz AC; Petrillo SK; Milosevic M; Craighead PS; Clarke B; Lees-Miller SP; Fyles AW; Magliocco AM
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):721-7. PubMed ID: 22836058
[TBL] [Abstract][Full Text] [Related]
32. Hypoxic versus normoxic external-beam irradiation of cervical carcinoma combined with californium-252 neutron brachytherapy. Comparative treatment results of a 5-year randomized study.
Tacev T; Vacek A; Ptácková B; Strnad V
Strahlenther Onkol; 2005 May; 181(5):273-84. PubMed ID: 15900423
[TBL] [Abstract][Full Text] [Related]
33. [Preoperative concurrent radiation therapy and chemotherapy for operable bulky carcinomas of uterine cervix stages IB2, IIA, and IIB with proximal parametrial invasion].
Lerouge D; Touboul E; Lefranc JP; Uzan S; Jannet D; Moureau-Zabotto L; Genestie C; Antoine M; Jamali M
Cancer Radiother; 2004 Jun; 8(3):168-77. PubMed ID: 15217584
[TBL] [Abstract][Full Text] [Related]
34. Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
Kim YB; Kim GE; Pyo HR; Cho NH; Keum KC; Lee CG; Seong J; Suh CO; Park TK
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):822-9. PubMed ID: 15465199
[TBL] [Abstract][Full Text] [Related]
35. Patterns of spread in node-positive cervical cancer: the relationship between local control and distant metastases.
Stock RG; Chen AS; Karasek K
Cancer J Sci Am; 1996; 2(5):256-62. PubMed ID: 9166542
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of Bax, Bcl-2, and p53 expressions in cervical squamous cell carcinoma treated by radiotherapy.
Wootipoom V; Lekhyananda N; Phungrassami T; Boonyaphiphat P; Thongsuksai P
Gynecol Oncol; 2004 Sep; 94(3):636-42. PubMed ID: 15350352
[TBL] [Abstract][Full Text] [Related]
37. Risk stratification of patients with advanced squamous cell carcinoma of cervix treated by radiotherapy alone.
Hong JH; Tsai CS; Lai CH; Chang TC; Wang CC; Chou HH; Lee SP; Lee CC; Tang SG; Hsueh S
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):492-9. PubMed ID: 15925454
[TBL] [Abstract][Full Text] [Related]
38. Pretreatment proliferation parameters do not add predictive power to clinical factors in cervical cancer treated with definitive radiation therapy.
Tsang RW; Juvet S; Pintilie M; Hill RP; Wong CS; Milosevic M; Chapman W; Levin W; Manchul LA; Fykes AW
Clin Cancer Res; 2003 Oct; 9(12):4387-95. PubMed ID: 14555510
[TBL] [Abstract][Full Text] [Related]
39. Differential expression of STAT5 and Bcl-xL, and high expression of Neu and STAT3 in non-small-cell lung carcinoma.
Sánchez-Ceja SG; Reyes-Maldonado E; Vázquez-Manríquez ME; López-Luna JJ; Belmont A; Gutiérrez-Castellanos S
Lung Cancer; 2006 Nov; 54(2):163-8. PubMed ID: 16959370
[TBL] [Abstract][Full Text] [Related]
40. Clinico-morphological parameters affecting survival of patients with advanced cervical cancer.
Klimek M; Kruczak A; Ryś J; Mularz K; Halaszka K; Przewoźnik M; Moskal J; Sokołowski A; Urbański K
Pol J Pathol; 2011 Dec; 62(4):250-6. PubMed ID: 22246911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
